These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1750 related items for PubMed ID: 15655711

  • 1. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M, Ahrén B.
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [Abstract] [Full Text] [Related]

  • 2. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.
    Peyot ML, Nolan CJ, Soni K, Joly E, Lussier R, Corkey BE, Wang SP, Mitchell GA, Prentki M.
    Diabetes; 2004 Jul; 53(7):1733-42. PubMed ID: 15220197
    [Abstract] [Full Text] [Related]

  • 3. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS, Ahrén B.
    J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
    [Abstract] [Full Text] [Related]

  • 4. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG, Pittner R, Jodka C, Smith P, Young A.
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
    Arakawa M, Ebato C, Mita T, Hirose T, Kawamori R, Fujitani Y, Watada H.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):809-14. PubMed ID: 19836346
    [Abstract] [Full Text] [Related]

  • 7. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ.
    Expert Opin Emerg Drugs; 2004 May 18; 9(1):155-66. PubMed ID: 15155141
    [Abstract] [Full Text] [Related]

  • 8. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D, Van Breusegem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F.
    Diabetes; 1998 Apr 18; 47(4):646-52. PubMed ID: 9568699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.
    Nielsen LL, Young AA, Parkes DG.
    Regul Pept; 2004 Feb 15; 117(2):77-88. PubMed ID: 14700743
    [Abstract] [Full Text] [Related]

  • 11. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
    Peyot ML, Gray JP, Lamontagne J, Smith PJ, Holz GG, Madiraju SR, Prentki M, Heart E.
    PLoS One; 2009 Jul 13; 4(7):e6221. PubMed ID: 19593440
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S, de Kort M, Irwin N, Moffett RC, Dokter WH, Bos ES, Miltenburg AM, Flatt PR.
    Diabetes Obes Metab; 2015 Aug 13; 17(8):760-70. PubMed ID: 25929155
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT).
    Yaney GC, Civelek VN, Richard AM, Dillon JS, Deeney JT, Hamilton JA, Korchak HM, Tornheim K, Corkey BE, Boyd AE.
    Diabetes; 2001 Jan 13; 50(1):56-62. PubMed ID: 11147795
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats.
    Wu L, Olverling A, Huang Z, Jansson L, Chao H, Gao X, Sjöholm Å.
    Clin Sci (Lond); 2012 Apr 13; 122(8):375-84. PubMed ID: 22054347
    [Abstract] [Full Text] [Related]

  • 19. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
    Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM.
    Diabetes; 2000 May 13; 49(5):741-8. PubMed ID: 10905482
    [Abstract] [Full Text] [Related]

  • 20. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
    Cabrera O, Ficorilli J, Shaw J, Echeverri F, Schwede F, Chepurny OG, Leech CA, Holz GG.
    J Biol Chem; 2022 Feb 13; 298(2):101484. PubMed ID: 34896391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.